Apollo Hospitals Enterprise on Tuesday reported a better-than-expected set of results for the October-December period, with a 34.9 per cent year-on-year surge in its consolidated net profit to Rs 502.3 crore.
The hospital chain’s top line expanded 17.2 per cent to Rs 6,477.4 crore, according to a regulatory filing.
Both net profit and revenue beat analysts’ expectations.
According to Zee Business research, Apollo Hospitals was estimated to register a net profit of Rs 465 crore and revenue of Rs 5,843 crore.
The Chennai-headquartered hospital chain said its consolidated earnings were supported by strong revenue and EBITDA growth across its three business verticals.
Apollo Hospitals Enterprise’s third-quarter margin improved by 110 basis points — or 1.1 percentage points — to 14.9 per cent.
The company said its consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 27 per cent to Rs 965 crore.
Apollo Hospitals management commentary
Apollo Hospitals Enterprise Chairman Dr Prathap C Reddy said the third-quarter performance reflects its fundamental strength and the clinical depth of its integrated care model.
“Across our network, teams are consistently delivering strong outcomes through disciplined execution in patient safety, quality, and experience. This quarter, sustained investments in advanced clinical capability translated into meaningful progress across key specialties from Apollo OMR completing 150 robotic joint replacement surgeries in its first 150 days, to the expansion of our stroke care network in Chennai with nine advanced stroke labs, strengthening rapidaccess care and outcomes,” he said.
He also said that the Union Budget for FY27 provides an important tailwind to the country’s aspiration to become a global destination for healthcare. The proposal to support states in establishing five regional medical hubs through public-private partnership, he said, is a strategic step toward building a high-quality, well-coordinated medical value travel ecosystem.
He said Apollo views medical value travel as a long-term national mission that reflects the country’s depth of clinical expertise, outcomes excellence and cost advantage.
Apollo Hospitals dividend
The company announced an interim dividend of Rs 10 per equity share — a 200 per cent payout given the face value of Rs 5 per equity share — with a record date of February 16.
The dividend will be paid on or before February 27, it noted.
Apollo Hospitals said revenue from its healthcare service segment grew 14 per cent to Rs 3,183 crore, while its EBITDA increased 18 per cent to Rs 790 crore
The unit’s margin stood at 24.8 per cent, it added.
Apollo Hospitals shares
Earlier on Tuesday, Apollo Hospitals Enterprise shares inched up 0.1 per cent to end at Rs 7,220 apiece on BSE in a Mumbai market where benchmark indices rose for a third straight session.
The Apollo Hospitals stock has risen 1.5 per cent so far this year, better than a 0.8 per cent decline in the Nifty50.
Doonited Affiliated: Syndicate News Hunt
This report has been published as part of an auto-generated syndicated wire feed. Except for the headline, the content has not been modified or edited by Doonited
